News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
September 21, 2021
2021

Lilly to Supply the EU and EEA with up to 220,000 Doses of Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19

Read article
News
September 16, 2021
2021

Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19

Read article
News
September 15, 2021
2021

AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines

Read article
News
September 13, 2021
2021

AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

Read article
News
September 10, 2021
2021

AbCellera to Present Virtually at the BofA Securities & Tech Solutions for Drug Discovery Conference

Read article
Event
August 21, 2021
2021

Antibody Engineering & Therapeutics US 2021

Read article
Event
August 21, 2021
2021

PEGS Europe 2021

Read article
Event
August 21, 2021
2021

Discovery on Target 2021

Read article
Event
August 21, 2021
2021

Festival of Biologics EU 2021

Read article
News
August 12, 2021
2021

AbCellera Reports Q2 2021 Business Results

Read article